- Home
- NGVC vs IOVA Comparison
NGVC vs IOVA Comparison
Compare NGVC & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NGVC
- IOVA
- Stock Information
- Founded
- NGVC 1955
- IOVA 2007
- Country
- NGVC United States
- IOVA United States
- Employees
- NGVC N/A
- IOVA N/A
- Industry
- NGVC Food Chains
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NGVC Consumer Staples
- IOVA Health Care
- Exchange
- NGVC Nasdaq
- IOVA Nasdaq
- Market Cap
- NGVC 890.8M
- IOVA 975.1M
- IPO Year
- NGVC 2012
- IOVA N/A
- Fundamental
- Price
- NGVC $38.15
- IOVA $2.38
- Analyst Decision
- NGVC
- IOVA Buy
- Analyst Count
- NGVC 0
- IOVA 11
- Target Price
- NGVC N/A
- IOVA $11.90
- AVG Volume (30 Days)
- NGVC 245.0K
- IOVA 11.2M
- Earning Date
- NGVC 08-07-2025
- IOVA 11-06-2025
- Dividend Yield
- NGVC 1.27%
- IOVA N/A
- EPS Growth
- NGVC 40.24
- IOVA N/A
- EPS
- NGVC 1.88
- IOVA N/A
- Revenue
- NGVC $1,317,356,000.00
- IOVA $241,525,000.00
- Revenue This Year
- NGVC $1.32
- IOVA $67.40
- Revenue Next Year
- NGVC N/A
- IOVA $56.32
- P/E Ratio
- NGVC $19.31
- IOVA N/A
- Revenue Growth
- NGVC 8.51
- IOVA 636.99
- 52 Week Low
- NGVC $24.99
- IOVA $1.64
- 52 Week High
- NGVC $61.22
- IOVA $12.51
- Technical
- Relative Strength Index (RSI)
- NGVC 46.70
- IOVA 49.08
- Support Level
- NGVC $35.86
- IOVA $2.27
- Resistance Level
- NGVC $38.06
- IOVA $2.46
- Average True Range (ATR)
- NGVC 1.38
- IOVA 0.14
- MACD
- NGVC -0.18
- IOVA 0.00
- Stochastic Oscillator
- NGVC 41.25
- IOVA 49.09
About NGVC Natural Grocers by Vitamin Cottage Inc.
Natural Grocers by Vitamin Cottage Inc operates natural and organic grocery and dietary supplement stores. It offers the following product categories, natural and organic food, dietary supplements, natural body care, household, pet care products, books and handouts. The Company has a single reporting segment, natural and organic retail stores, through which business are conducted. The company generates the majority of its revenue from grocery products and dietary supplements and rest from other products.
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.